secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zoetis Inc. (ZTS)
CIK:        0001555280
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001555280-25-000259
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zoetis Q2 revenue $2.5B (+4% reported, +8% organic); raises FY2025 guidance
---------------------------------------------------------------------------

- Reported net income $718M ($1.61 diluted EPS), up 15% YoY; adjusted EPS $1.76, up 13%.
- U.S. segment revenue $1.4B (+4% reported, +7% organic); companion animal product sales up 9%.
- International segment revenue $1.1B (+3% reported, +9% organic); livestock sales up 10% organic.
- Raised FY2025 revenue guidance to $9.45-9.60B (organic growth 6.5-8.0%); adjusted EPS $6.30-6.40.
- Simparica Trio gained new label in Japan; avian influenza vaccine conditionally licensed for U.S. dairy cattle.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/0001555280-25-000259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000259/zts-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001555280-25-000259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer